| Date | Title | |
| 02/08/10 | Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates
Dose-Related Immune Response in Clinical Trial |  |
| 02/03/10 | Inovio Biomedical to Present at BIO CEO & Investor Conference | |
| 01/27/10 | Inovio Unveils Skin Electroporation Technology for Delivering DNA Vaccines | |
| 01/19/10 | Inovio Biomedical to Present at Partnering and Vaccine Conferences | |
| 01/11/10 | Inovio Expands DNA Vaccine Intellectual Property License with
University of Pennsylvania | |
| 01/07/10 | Inovio Biomedical to Present at OneMedForum Investor Conference | |
| 01/06/10 | VGX Animal Health’s Growth Hormone Releasing Hormone Shows Advantages Compared to Current Growth Hormone Therapies Used in Pigs | |
| 01/05/10 | Inovio Appoints Dr. Mark Bagarazzi as Chief Medical Officer | |
| 12/21/09 | Inovio Biomedical Appoints Electroporation Delivery Expert Dr. Iacob Mathiesen to Its Scientific Advisory Board | |
| 11/30/09 | Inovio Partner Announces Completion of Phase I DNA Vaccine Study | |
| 11/20/09 | Inovio Biomedical Universal Flu Vaccines Demonstrate Broadly Protective Immune Responses Against Multiple Seasonal & Pandemic Influenza Viruses in Pre-Clinical Studies | |
| 11/18/09 | Inovio Biomedical Universal DNA Vaccine for Chikungunya Virus Demonstrates Protective Antibody Responses in Monkey Model | |
| 11/16/09 | Therapeutic DNA Vaccine Company Inovio Biomedical Reports Third Quarter 2009 Financial Results | |
| 11/12/09 | Inovio Biomedical to Present at Global Vaccine Conferences | |
| 10/26/09 | Inovio Biomedical Board of Directors Adds Two New Members | |
| 10/21/09 | Inovio Biomedical to Present at Investor Conferences | |
| 10/20/09 | Inovio Biomedical and Its Collaborators Present Research and Clinical Data at AIDS Vaccine 2009 Conference | |
| 10/15/09 | Inovio Biomedical Announces Initiation of HIV Clinical Trial for DNA Vaccine Delivered Using Electroporation | |
| 10/13/09 | Inovio Biomedical CEO Introduces DNA Vaccine Potential at 2009 World Knowledge Forum | |
| 10/05/09 | Inovio Biomedical Demonstrates Protective Immune Responses Against Novel H1N1 (2009) Influenza Virus in Ferret Model | |
| 10/05/09 | Inovio Biomedical Therapeutic Cervical Cancer Vaccine Demonstrates Safety and Immunogenicity in Clinical Trial | |
| 09/28/09 | Inovio Biomedical to Present at Vaccine 3rd Global Congress | |
| 09/24/09 | Inovio Biomedical CEO Addresses MIT's Emerging Technologies Conference | |
| 09/16/09 | Inovio Biomedical CEO to Present at MIT Technology Review Emerging Technology Conference | |
| 09/03/09 | Enabling Capabilities of Inovio Biomedical's Electroporation Delivery Technology with SIV DNA Vaccine Confirmed in Collaborative Study With National Cancer Institute | |
| 08/31/09 | DNA Vaccine Company Inovio Biomedical to Present at Rodman & Renshaw Investor Healthcare Conference | |
| 08/19/09 | Therapeutic DNA Vaccine Company Inovio Biomedical Reports Second Quarter 2009 Financial Results | |
| 08/12/09 | Inovio Biomedical to Present at Novel Vaccines: Design & Development | |
| 08/10/09 | Inovio Biomedical and NIH Vaccine Research Center Sign Research Collaboration Agreement to Develop Universal Influenza Vaccines | |
| 08/05/09 | First Human Demonstration of Significant, Persistent Antibody Response Using Electroporation-Delivered DNA Vaccine Published in Human Gene Therapy | |
| 07/31/09 | Inovio Closes $30 Million Registered Direct Offering | |
| 07/30/09 | Inovio Announces $30 Million Registered Direct Offering | |
| 07/29/09 | Inovio Biomedical Universal Influenza Vaccines Demonstrate 100% Protection Against Current Pandemic A/H1N1 Influenza Viruses in Animal Studies | |
| 07/27/09 | Inovio Biomedical Universal Dengue DNA Vaccine Demonstrates Strong Immune Responses Against All Four Serotypes | |
| 07/27/09 | Inovio Biomedical to Present at Jesup & Lamont Growth Stock Conference | |
| 07/13/09 | Inovio Biomedical H1N1 Influenza DNA Vaccines Demonstrate 100% Responses Against Swine Flu in Vaccinated Pigs | |
| 07/06/09 | Inovio Biomedical to Present at International DNA Vaccine Conference | |
| 06/30/09 | Inovio Biomedical, National Microbiology Laboratory, and University of Pennsylvania to Evaluate Candidate DNA Vaccines against "Swine" Influenza A (H1N1) | |
| 06/24/09 | Vaccine Pioneer Joins Inovio Biomedical's Scientific Advisory Board | |
| 06/15/09 | Inovio Biomedical Grants Option for Intravascular Applications of its Electroporation Technology to Cardigant Medical | |
| 06/04/09 | Inovio Biomedical to Present at 8th Annual Needham Life Sciences Conference | |
| 06/02/09 | Inovio Biomedical Influenza DNA Vaccines Demonstrate Potential to Protect Against Newly Emerging Flu Strains with Pandemic Potential | |
| 06/01/09 | Inovio Biomedical Closes Merger with VGX Pharmaceuticals to Form a Leading Vaccine Discovery, Development and Delivery Company | |
| 05/29/09 | Inovio Biomedical and VGX Pharmaceuticals Stockholders Overwhelmingly Approve Proposed Merger | |
| 05/14/09 | Inovio Biomedical Reports First Quarter 2009 Financial Results | |
| 05/01/09 | Inovio Biomedical's Registration Statement in Connection with Proposed Merger with VGX Pharmaceuticals Declared Effective | |
| 05/01/09 | VGX Pharmaceuticals’ Registration Statement in Connection with Proposed Merger with Inovio Biomedical Declared Effective | |
| 04/06/09 | Ng Tee Khiang Appointed to Inovio Biomedical's Board of Directors | |
| 03/31/09 | Inovio Biomedical and VGX Pharmaceuticals Extend Completion Date for Definitive Merger Agreement | |
| 03/31/09 | Inovio Biomedical Reports 4(th) Quarter and Year-End 2008 Financial Results | |
| 03/31/09 | VGX Pharmaceuticals and Inovio Biomedical Extend Completion Date for Definitive Merger Agreement | |
| 03/26/09 | VGX Pharmaceuticals’ Oral Anti-Inflammatory Drug Safe in Phase I Study | |
| 03/23/09 | VGX Pharmaceuticals Announces Agreement With the PATH Malaria Vaccine Initiative | |
| 02/23/09 | VGX Pharmaceuticals Avian Influenza DNA Vaccine Delivered with Electroporation Provides 100% Protection of Non-Human Primates | |
| 02/18/09 | VGX Pharmaceuticals Proprietary DNA Vaccines Delivered with Electroporation Achieve Immune Responses Superior to Recombinant Adenovirus Serotype 5 (Ad5) Vectors | |
| 02/13/09 | VGX Pharmaceuticals Announces Filing of Device Master File Amendment with the FDA for CELLECTRA® Device – Intradermal Electroporation (ID-EP) | |
| 02/06/09 | Director Resigns from Inovio Biomedical's Board | |
| 12/18/08 | VGX Pharmaceuticals Presents Electroporation-Delivered Vaccine Data at DNA Vaccines 2008 Conference | |
| 12/17/08 | Inovio Biomedical's Advances in Electroporation-Delivered Therapeutic Vaccines Presented at International DNA Vaccine Conference | |
| 12/08/08 | Chin-Cheong Chong Elected to Inovio Biomedical's Board of Directors | |
| 12/08/08 | Inovio Biomedical and VGX Pharmaceuticals Amend Merger Agreement | |
| 12/08/08 | Inovio Biomedical and VGX Pharmaceuticals Amend Merger Agreement | |
| 12/04/08 | Inovio Biomedical and VGX Pharmaceuticals to Highlight Recent Advances in Electroporation-Delivered DNA Vaccines at International DNA Vaccines Conference | |
| 12/04/08 | Inovio Biomedical and VGX Pharmaceuticals to Highlight Recent Advances in Electroporation-Delivered DNA Vaccines at International DNA Vaccines Conference | |
| 12/02/08 | First-Ever Human Trial of DNA-Based Immunotherapy Delivered Using Inovio Biomedical's Electroporation Technology Shows Safety and Durable Systemic Clinical Response | |
| 11/17/08 | Hepatitis C Therapeutic DNA Vaccine Delivered by Inovio Biomedical's Electroporation Technology Reduces Viral Load by Up to 99.7% | |
| 11/07/08 | DNA Vaccine Company Inovio Biomedical Reports Third Quarter 2008 Financial Results | |
| 10/15/08 | VGX Pharmaceuticals Presents Non-human Primate Study Data at AIDS Vaccine 2008 Conference | |
| 10/07/08 | VGX Animal Health announces the commercialization of its LifeTide™ SW 5 GHRH gene therapy product for pigs in Australia | |
| 10/01/08 | VGX Pharmaceuticals Awarded $23.5 Million NIH Contract to Develop DNA-Based Preventive HIV Vaccine Delivered Via Electroporation | |
| 09/29/08 | VGX Pharmaceuticals commences follow-on Phase I study for novel oral anti-inflammatory drug targeting rheumatoid arthritis and Type 1 diabetes | |
| 09/23/08 | Inovio Awarded US Army Contract for Bio-Defense Vaccine Research Using its Electroporation Delivery Technology | |
| 09/14/08 | Inovio Biomedical Achieves 75% Complete Response Rate in Preclinical Testing of DNA-Based Cancer Vaccine Using Its Electroporation DNA Delivery System | |
| 08/25/08 | VGX Pharmaceuticals announces the publication of pivotal data from its LifeTide™ SW 5 studies, which led to the approval in Australia of the GHRH gene therapy product for pigs | |
| 08/14/08 | Inovio Biomedical Expands In Vivo Electroporation License with International AIDS Vaccine Initiative for HIV Vaccine Research | |
| 08/07/08 | Therapeutic DNA Vaccine Company Inovio Biomedical Reports Second Quarter 2008 Financial Results | |
| 07/16/08 | Inovio Biomedical's First Proprietary DNA Vaccine Achieves 100% Protection Against Avian Flu in Pre-Clinical Testing | |
| 07/15/08 | Inovio Biomedical to Highlight Electroporation-Based DNA Vaccine Delivery at Scientific Conferences | |
| 07/07/08 | Inovio Biomedical and VGX Pharmaceuticals Sign Merger Agreement | |
| 07/07/08 | VGX Pharmaceuticals announces the discontinuation of its PICTOVIR™ Program | |
| 07/07/08 | Inovio Biomedical and VGX Pharmaceuticals Sign Merger Agreement | |
| 07/01/08 | VGX Pharmaceuticals receives FDA approval of IND for novel DNA vaccine for cervical cancer therapy | |
| 06/30/08 | Early Results from Ongoing Clinical Study of Hepatitis C Vaccine Delivered by Inovio Biomedical's Electroporation System Show Increased T-Cell Responses and Reduced Viral Loads | |
| 06/25/08 | VGX announces publication of preclinical data for the Company’s avian flu vaccine candidate in PLoS ONE journal | |
| 06/23/08 | VGX Licenses Additional DNA Vaccines Technology from the University of Pennsylvania | |
| 06/17/08 | Therapeutic DNA Vaccine Company Inovio Biomedical Presenting at BIO International | |
| 06/17/08 | VGX Gene Therapy Technology Featured at the 90th Annual Endocrine Society Meeting | |
| 06/12/08 | VGX Collaborators to present Chikungunya Vaccine Research at the 13th International Congress on Infectious Diseases | |
| 06/05/08 | Inovio Biomedical Provides Updated Interim Data on Phase I/II Clinical Study of Electroporation-Delivered Prostate Cancer DNA Vaccine at ASGT Annual Meeting | |
| 06/04/08 | Reduced Hepatitis C Viral Level Achieved with DNA Vaccine Delivered by Inovio Biomedical's Electroporation Delivery System in Phase I/II Clinical Study | |
| 06/03/08 | VGX Pharmaceuticals Announces Reorganization of its Manufacturing Assets | |
| 06/02/08 | VGX Pharmaceuticals Announces Management Promotion | |
| 05/28/08 | VGX Pharmaceuticals to Make Multiple Presentations at the American Society of Gene Therapy Meeting Showcasing its Patented CELLECTRA® Electroporation Device for DNA Delivery and its DNA Manufacturing Process. | |
| 05/27/08 | Inovio Biomedical Licenses Electroporation Delivery Technology to Leading U.S. Government Contractor, Advanced BioScience Laboratories, Inc. | |
| 05/22/08 | VGX Pharmaceuticals announces publication in Molecular Therapy regarding the Company’s GHRH gene therapy product | |
| 05/20/08 | Therapeutic DNA Vaccine Company Inovio Biomedical to Present at Upcoming Scientific Conferences | |
| 05/19/08 | VGX Pharmaceuticals announces filings of two separate INDs covering novel DNA vaccines: one for the cervical cancer therapy (VGX-3100) and one for avian influenza (VGX-3400) | |
| 05/12/08 | VGX Pharmaceuticals signs multi-year production agreement with the United Kingdom Cystic Fibrosis Gene Therapy Consortium | |
| 05/09/08 | Therapeutic DNA Vaccine Company Inovio Biomedical Reports First Quarter 2008 Financial Results | |
| 05/08/08 | Patrick Gan Elected to Inovio Biomedical Board of Directors | |
| 05/05/08 | VGX Pharmaceuticals to present at the 11th Annual Conference on Vaccine Research | |
| 04/16/08 | VGX Pharmaceuticals announces a license agreement with VGX International to use CELLECTRA™ electroporation device to develop new DNA-based vaccines and therapies | |
| 04/09/08 | Therapeutic Vaccine Company Inovio Biomedical Demonstrates Utility of Its Electroporation Delivery Technology as Potent Vaccine Adjuvant | |
| 04/04/08 | Prostate Cancer DNA Vaccine Results in Higher T-Cell Response When Delivered via Inovio Biomedical's Electroporation Delivery System | |
| 03/17/08 | Therapeutic DNA Vaccine Company Inovio Biomedical Reports 4th Quarter and Year-End 2007 Financial Results | |
| 03/17/08 | Hepatitis C Virus DNA Vaccine Shows Safety When Delivered by Inovio Biomedical's Electroporation Delivery System in Phase I/II Clinical Study at Karolinska University Hospital | |
| 03/11/08 | Inovio Biomedical's Electroporation Delivery Technology Demonstrates Safety and Positive Clinical Responses with Melanoma DNA Immunotherapy | |
| 03/04/08 | Inovio Biomedical to Present New Data from Melanoma Immunotherapy Clinical Trial at DNA Vaccines Forum 2008 | |
| 02/29/08 | VGX Pharmaceuticals Co-Founder Professor David B. Weiner to Chair the First DNA Vaccines Conference in Asia | |
| 02/20/08 | Therapeutic DNA-Vaccine Company Inovio Biomedical Appoints Dr. Stephen Rietiker as a Director | |
| 02/08/08 | VGX Pharmaceuticals announces the IND filing of VGX-3200, a novel DNA therapy that utilizes GHRH for the treatment of cancer cachexia and anemia | |
| 02/05/08 | VGX Pharmaceuticals Announces Initiation of VGX-cGMP Manufactured Plasmid Products in Clinical Use by Partners | |
| 01/30/08 | Therapeutic DNA Vaccine Delivery via Inovio's Electroporation Technology Featured in Nature Reviews Cancer | |
| 01/30/08 | Therapeutic DNA Vaccine Company, Inovio Biomedical, Promotes Punit Dhillon to Vice President of Finance & Operations | |
| 01/24/08 | Therapeutic DNA Vaccine Company Inovio Biomedical Corp. Announces 'Clinical Trials Update' Conference Call on Jan. 29 | |
| 01/21/08 | VGX Pharmaceuticals Submits Device Master File to FDA for CELLECTRA™ Electroporator | |
| 01/14/08 | VGX Pharmaceuticals receives FDA clearance to commence clinical trials of VGX-1027, a novel oral drug with potent anti-inflammatory activity | |
| 01/09/08 | VGX Animal Health announces approval of LifeTide™ SW 5 - World’s First and Only Approved DNA Therapy for Food Animals | |
| 12/27/07 | VGX Pharmaceuticals announces successful completion of the first human study to assess the tolerability of CELLECTRA™ electroporator | |
| 12/20/07 | VGX Pharmaceuticals announces IND filing of VGX-1027, a novel small molecule compound with potent anti-inflammatory activity | |
| 12/13/07 | VGX Pharmaceuticals announces the discontinuation of VGX-410C development and the concentration of its efforts on HIV and other product pipelines | |
| 12/12/07 | Inovio Biomedical Receives Additional Milestone Payment from Merck Relating to Electroporation Delivery System for DNA Vaccines | |
| 11/27/07 | Inovio Biomedical Partner Tripep Treats First Subject in Phase I/II Study of Novel Hepatitis C DNA Vaccine | |
| 11/14/07 | Inovio Biomedical to Present DNA Vaccine Overview at Scientific Meeting | |
| 11/12/07 | VGX Pharmaceuticals' SynCon™ Pandemic Flu Vaccine Protects Against A Lethal Challenge of Live Virus in Pre-Clinical Animal Models | |
| 11/08/07 | Inovio Reports Third Quarter 2007 Financial Results | |
| 11/07/07 | VGX Pharmaceuticals Announces Executive Promotions | |
| 10/31/07 | Inovio Biomedical to Present at Upcoming Conferences | |
| 10/30/07 | Inovio Biomedical's DNA Vaccine Delivery Technology Moves Ahead in Clinical Trial for Hepatitis C | |
| 10/29/07 | VGX Pharmaceuticals announces an agreement with VGX International to build a large scale cGMP DNA manufacturing plant in Korea | |
| 10/17/07 | VGX Pharmaceuticals provides clinical trials and product development updates | |
| 10/09/07 | Inovio Biomedical Redirects Strategic Emphasis toward DNA Vaccines and DNA Delivery | |
| 10/08/07 | VGX Pharmaceuticals to present at the Second International Conference on Cancer Vaccines/Adjuvants/Delivery | |
| 10/03/07 | Inovio Biomedical to Present at BIO InvestorForum 2007 | |
| 09/19/07 | VGX Pharmaceuticals closes investment by the Korea Development Bank | |
| 09/10/07 | VGX Pharmaceuticals Receives $1.9 Million Contract from U.S. Government to Develop Skin Micro-Electroporation for Improved Biodefense Vaccine Efficacy | |
| 09/04/07 | Inovio CEO to Present at Thomas Weisel Healthcare Conference | |
| 09/02/07 | VGX Pharmaceuticals Announces the Completion of Patient Enrollment for the Company’s Phase II Trial for VGX-410C | |
| 08/21/07 | Inovio Biomedical Appoints Dr. Michael Fons as Vice President, Corporate Development | |
| 08/20/07 | VGX DNA vaccine primate study results to be presented at the AIDS Vaccine 2007 Conference | |
| 08/16/07 | Inovio Biomedical Partner Tripep Receives Approval to Initiate Phase I/II Study of Novel Vaccine for Hepatitis C Virus | |
| 08/15/07 | VGX Pharmaceuticals Announces Initiation of IND-enabling Toxicology Studies for Candidate DNA Vaccine Products | |
| 08/08/07 | Inovio Reports Second Quarter 2007 Financial Results | |
| 07/24/07 | Inovio Biomedical Establishes Agreements with National Cancer Institute and International Aids Vaccine Initiative to Conduct Research Using Inovio's DNA Delivery Technology | |
| 07/19/07 | VGX Pharmaceuticals Announces Issuance of a Key U.S. Patent Covering New Electroporation Technology for Delivery of Macromolecules to Cells | |
| 07/17/07 | VGX strengthens its plasmid position | |
| 07/11/07 | VGX Pharmaceuticals Announces Issuance of Two Key U.S. Patents Covering DNA Plasmid Manufacturing Technology and the Treatment of Anemia | |
| 07/01/07 | VGX Pharmaceuticals Announces Promotion of Bryan Kim, D.M.D. to Vice President of Asian Operations | |
| 06/20/07 | VGX Pharmaceuticals Announces an R&D and License Agreement with VGX International to Develop Gastric Cancer Therapeutics | |
| 06/19/07 | Inovio Biomedical's Selective Electrochemical Tumor Ablation Therapy Shows Safety, Tolerability, and Significant Complete Responses in Breast Cancer Study | |
| 06/15/07 | VGX International Inc. Added to the KOSPI 200 Index | |
| 06/07/07 | Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedical's Electroporation DNA Delivery Technology | |
| 06/06/07 | Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with Electroporation DNA Delivery Technology and New Devices at Gene Therapy Meeting | |
| 06/05/07 | Inovio Biomedical Stops Enrollment of Phase III Clinical Trials for Head & Neck Cancer | |
| 05/31/07 | VGX Pharmaceuticals Announces Formation of Animal Health Company | |
| 05/30/07 | Inovio Biomedical to Present at American Society of Gene Therapy Meeting | |
| 05/30/07 | VGX Pharmaceuticals to Present at American Society of Gene Therapy Meeting | |
| 05/25/07 | Inovio Biomedical Closes $16.17 Million Equity Financing | |
| 05/24/07 | Inovio Biomedical's DNA Delivery Technology Shows Safety and Enhances Gene Expression & Tumor Responses in Interim Melanoma Clinical Study Results | |
| 05/23/07 | VGX Pharmaceuticals' Novel HIV and Pandemic Influenza DNA Vaccine Candidates Trigger Robust Immune Responses and Protection in Pre-Clinical Models | |
| 05/22/07 | Inovio Biomedical's DNA Delivery Technology Significantly Enhances Potency of Gene-Based Prostate Cancer Vaccine | |
| 05/22/07 | Inovio Biomedical to Present at Vaccine Development Conference | |
| 05/21/07 | Inovio Biomedical Partner Tripep Provides Update on its Hepatitis C DNA Vaccine Program | |
| 05/21/07 | VGX Pharmaceuticals Co-Founder Professor David B. Weiner to Chair International Scientific Congress | |
| 05/17/07 | Inovio Biomedical's Partners to Present New Data from Two Cancer Immunotherapy Clinical Trials | |
| 05/16/07 | Inovio to Raise Approximately $16.2 Million through Equity Funding | |
| 05/14/07 | VGX Pharmaceuticals Announces DNA Therapeutics License Agreement with Baylor College of Medicine | |
| 05/10/07 | Inovio to Present at Acumen BioFin 4th Annual Global Healthcare Conference | |
| 05/09/07 | Inovio Reports First Quarter 2007 Financial Results | |
| 05/08/07 | Inovio Biomedical Elects Bob Rieder to its Board of Directors | |
| 05/08/07 | VGX Pharmaceuticals Announces Publication of Preclinical Efficacy Studies for VGX-1027 for Various Inflammatory Diseases | |
| 05/04/07 | Inovio Biomedical to Present at BIO International Convention 2007 | |
| 05/02/07 | Diosynth Biotechnology Announces Agreement With VGX Pharmaceuticals For Process Development And Clinical Production Of VGX-100 For The Treatment Of Cancer | |
| 05/02/07 | VGX Pharmaceuticals Strengthens Management Team with Two New Appointments: Dorothy Peterson Appointed as Director of Quality Debra A. Bacino Appointed as Controller | |
| 05/01/07 | DowpharmaSM Licenses Pf nex Expression Technology™to VGX Pharmaceuticals | |
| 04/05/07 | Inovio Biomedical's DNA Delivery Technology for Immunotherapy to Be Presented at Drug Delivery Conference | |
| 03/30/07 | Inovio Biomedical to Present New Research and Technology Innovations at Bioelectrochemistry Symposium | |
| 03/26/07 | Inovio Biomedical's DNA Delivery Technology Significantly Enhances Potency of HIV DNA Vaccine | |
| 03/16/07 | Inovio Reports 2006 Financial Results | |
| 03/07/07 | Inovio's New Website - GeneSwitch.com - Supports Novel Gene Expression Technology | |
| 02/21/07 | VGX Pharmaceuticals Signs Marketing and License Agreement for Asia and Other Developing Regions | |
| 02/16/07 | Inovio Biomedical DNA Delivery Technology Presented by Wyeth Researcher at Vaccine Conference | |
| 02/14/07 | Inovio Biomedical Announces Needle-Free Electroporation Patent | |
| 02/07/07 | Inovio Biomedical to Present at BIO CEO & Investor Conference 2007 | |
| 02/01/07 | Inovio Presents MedPulser® Electrochemical Tumor Ablation Results at 5th International Symposium on Advances in Head & Neck Cancer | |
| 01/17/07 | Letter to Our Shareholders | |
| 12/18/06 | VGX Pharmaceuticals Announces an R&D and License Agreement with VGX International to Develop Novel Type 1 Diabetes Therapeutics | |
| 12/06/06 | VGX Pharmaceuticals Announces Publication of Preclinical Efficacy Studies for VGX-1027 for Treating Type 1 Diabetes | |
| 12/05/06 | Inovio Biomedical Partner Tripep Files Application for Phase I Clinical Study of Hepatitis C DNA Vaccine | |
| 12/01/06 | Inovio to Present at BIO Drug/Device Summit 2006 | |
| 11/14/06 | Inovio Biomedical Grants VGX Pharmaceuticals License to Develop Novel Cancer Therapeutic | |
| 11/14/06 | VGX Pharmaceuticals Announces a License Agreement with Inovio Biomedical to Develop Novel Cancer Therapeutics | |
| 11/13/06 | Webcast Alert: Inovio Biomedical Corporation Announces Its InformedInvestors.com Presentation Webcast | |
| 11/08/06 | Inovio Reports Third Quarter 2006 Financial Results | |
| 11/07/06 | Inovio Biomedical DNA Delivery Technology to be Presented at the Fifth World Congress on Vaccines by Researcher from Merck & Co., Inc. | |
| 11/07/06 | Inovio Biomedical Grants Wyeth Pharmaceuticals License to Develop Infectious Disease DNA Vaccines | |
| 11/07/06 | VGX-150 Animal Efficacy Study Featured in Molecular Therapy | |
| 11/01/06 | Inovio to Present at BIO-Europe International Partnering Conference | |
| 11/01/06 | Inovio to Present at Rodman & Renshaw 8th Annual Healthcare Conference | |
| 10/27/06 | VGX Pharmaceuticals Announces the Initiation of IND-enabling Toxicology Studies for VGX-1027 | |
| 10/26/06 | VGX Pharmaceuticals Announces New Product Marketing and Sales Plan for Asia and Other Developing Regions | |
| 10/24/06 | Inovio Biomedical and Tripep Advance Pre-Clinical Development of DNA Vaccine for Hepatitis C | |
| 10/19/06 | Inovio Biomedical to Receive $1.1 Million from U.S. Department of Defense to Apply its Gene Delivery Technology to Vaccines Relating to Biodefense | |
| 10/18/06 | VGX Pharmaceuticals Announces Management Promotions | |
| 10/17/06 | Inovio Biomedical Acquires Rights to DNA Vaccine Licenses and Intellectual Property from Valentis | |
| 10/16/06 | VGX Pharmaceuticals Announces the Completion of Financial Audits | |
| 10/13/06 | Inovio Biomedical Closes $15.25 Million Equity Financing | |
| 10/13/06 | Inovio to Present at BIO InvestorForum 2006 | |
| 10/13/06 | VGX Pharmaceuticals Completes Manufacturing of New Oncology Drug VGX-150 for Phase I Clinical Trials | |
| 09/27/06 | VGX Collaborators Present at the ICAAC | |
| 09/22/06 | VGX CEO named Among 50 Most Influential Men under 42 | |
| 09/18/06 | Inovio Forms Asian Subsidiary and To Raise Approximately $15.25 Million through Equity Funding | |
| 09/11/06 | VGX Pharmaceuticals Announces Publication of Preclinical Animal Efficacy Studies for VGX-150 in Molecular Therapy | |
| 09/06/06 | Inovio's Electroporation Patent Estate Expanded with the Allowance of Claims in Europe | |
| 09/05/06 | Study Results Point to Possible Application of Inovio's Electroporation-Based Therapy in Conjunction with Surgery to Treat Solid Tumor Margins | |
| 09/01/06 | Inovio's CEO to Present at Thomas Weisel Healthcare Conference | |
| 08/31/06 | VGX Pharmaceuticals Announces the Initiation of IND-enabling Toxicology Studies for VGX-150 | |
| 08/28/06 | Tripep Produces Additional Positive Data for Its Hepatitis C DNA Vaccine Using Inovio's DNA Delivery System | |
| 08/23/06 | VGX Pharmaceuticals announced the appointment of Niranjan Y. Sardesai, Ph.D. as Senior Director, Product Development | |
| 08/08/06 | Inovio Reports Second Quarter 2006 Financial Results | |
| 08/08/06 | VGX Pharmaceutical Announces Executive Resignation | |
| 07/25/06 | VGX Pharmaceutical Announces Executive Promotions | |
| 07/17/06 | VGX Pharmaceuticals Provides Update on Additional Phase II Clinical Trial for PICTOVIR™ | |
| 07/05/06 | Inovio's License of Electroporation Intellectual Property Includes Skin Delivery Technology Used in Anthrax Collaboration | |
| 07/01/06 | VGX Pharmaceuticals Announced the Appointment of Jessica C. Lee as Director, Clinical Development | |
| 06/19/06 | Inovio's Electroporation Technology Used by U.S. Army to Demonstrate Protection from Lethal Challenge with Possible Biological Warfare Agent; Pre-Clinical Study Shows Potential Benefit of Vaccine Against Lassa Fever Virus | |
| 06/06/06 | Inovio's Presentations at Gene Therapy Meeting Showcase Potential for Electroporation in Delivering DNA Vaccines and Gene-Based Treatments of Protein-Deficiency Diseases | |
| 06/01/06 | H. Lee Moffitt Cancer Center and Inovio Biomedical Announce Positive Results from Pioneering Human Study of Plasmid DNA Delivery Using Electroporation | |
| 05/31/06 | H. Lee Moffitt Cancer Center and Inovio Biomedical to Unveil Pioneering Clinical Study Data of Plasmid DNA Delivery Using Electroporation | |
| 05/30/06 | Inovio Highlights its Clinical & Technology Platforms for DNA Vaccines and Gene-Based Treatment of Protein-Deficiency Diseases at American Society of Gene Therapy Meeting | |
| 05/22/06 | VGX Co-Founder and Chief Medical Officer to Chair Vaccine Discovery and Commercialization Conference | |
| 05/15/06 | Inovio Acquires Intellectual Property Rights to Augment Patent Estate for Electroporation-Assisted DNA Delivery | |
| 05/15/06 | VGX Pharmaceuticals Announces a New Site Opening for Phase II Clinical Trials of VGX–410C for the Treatment of Chronic Hepatitis C Infection | |
| 05/10/06 | Inovio's CEO to Present at Rodman & Renshaw 3rd Annual Global Healthcare Conference | |
| 05/09/06 | Inovio Reports First Quarter 2006 Financial Results | |
| 05/01/06 | VGX Announces Promotion of Gene Kim as Chief Financial Officer | |
| 04/28/06 | VGX Pharmaceuticals Initiates Manufacturing of VGX-1027 for Phase I Clinical Trials | |
| 04/07/06 | VGX Pharmaceuticals Announces FDA Acceptance of IND for PICTOVIR™ | |
| 03/16/06 | Inovio Reports 2005 Financial Results | |
| 03/09/06 | VGX Pharmaceuticals Announces IND Submission for Additional Phase II Clinical Trials for PICTOVIR™ | |
| 02/28/06 | VGX Pharmaceuticals and DowpharmaSM Sign Research and Development Agreement for VGX’s Lead Cancer Compound - Pfenex Expression TechnologyTM Selected to Accelerate Development Cycle | |
| 02/22/06 | VGX Pharmaceuticals Enters In-Licensing Agreement with Ganial Immunotherapeutics, Inc. for Novel Drug Compound for Inflammatory Diseases | |
| 02/21/06 | Webcast Alert: Inovio Biomedical Corporation Presentation at Informed Investors Biotechnology / Healthcare On-line Investor Forum webcast on Thursday, February 23, 2006, 10:00 am ET | |
| 02/01/06 | Inovio's President and CEO to Present at BIO CEO 2006 | |
| 01/17/06 | Inovio Biomedical to Develop Vaccine for Hepatitis C in Partnership with Tripep AB | |
| 01/11/06 | Inovio Adds Significant Patents Relating to Electroporation-Enabled Delivery of Therapeutic Molecules | |
| 01/03/06 | Inovio Completes $15.8 Million Equity Funding | |
| 12/29/05 | VGX Pharmaceuticals Announces Preliminary Results on the Phase I/II Clinical Trials of PICTOVIR™ | |
| 12/22/05 | VGX Pharmaceuticals Announces Research Collaboration with the University of Pennsylvania | |
| 12/19/05 | Inovio to Raise Approximately $15.8 Million Through Equity Funding | |
| 11/18/05 | Published Study Shows Benefits of Inovio's Selective Electrochemical Tumor Ablation Therapy as Head and Neck Cancer Treatment Option | |
| 11/09/05 | Inovio Reports Third Quarter 2005 Financial Results | |
| 11/04/05 | Inovio's President and CEO to Present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference | |
| 10/20/05 | Inovio Initiates Recurrent Breast Cancer Clinical Trial Using Its Selective Electrochemical Tumor Ablation Therapy | |
| 10/17/05 | Inovio's President and CEO to Present at BIO InvestorForum 2005 | |
| 10/13/05 | Inovio Study Results of Gene-Based Therapies for HIV and Vascular Disease Published in Scientific Journals; Articles Published in Collaboration with Boehringer Ingelheim and Chiron Corporation | |
| 10/04/05 | Inovio Adds Patents for Transdermal Electroporation | |
| 09/27/05 | Study Results of Novel Inovio Electroporation Device for Gene Delivery Published in Vaccine Journal | |
| 09/26/05 | VGX Pharmaceuticals Initiates the Phase II Clinical Trials of VGX - 410C for the Treatment of Chronic Hepatitis C Infection | |
| 09/19/05 | Metastatic Melanoma Treatment Results Using Inovio's Selective Electrochemical Tumor Ablation Therapy Published in Melanoma Research | |
| 09/13/05 | Inovio Biomedical Awarded $1 Million by U.S. Department of Defense for Bioterrorism Collaboration with Leading Army Laboratory | |
| 09/06/05 | Inovio to Highlight the Treatment of Melanoma Using its Selective Electrochemical Tumor Ablation Therapy at 6th World Congress on Melanoma | |
| 08/21/05 | VGX Pharmaceuticals Announces FDA Acceptance of IND Application for VGX-410C | |
| 08/09/05 | Inovio Reports Second Quarter 2005 Financial Results | |
| 08/01/05 | VGX announced key management team promotions and additions | |
| 07/21/05 | VGX Pharmaceuticals Announces Filing of IND Application for the treatment of Hepatitis C infection | |
| 07/18/05 | Vical Begins Phase 1 Trial of Gene-Based IL-2 With Inovio Electroporation Technology | |
| 07/13/05 | Inovio Biomedical Receives Milestone Payment from Merck Regarding MedPulser® DNA Delivery System | |
| 06/07/05 | Forum Alert: Inovio Biomedical Corporation Will Present at the Informed Investors Biotechnology / Healthcare / Pharmaceutical Investor Forum at The Princeton Club of New York on Wednesday, June 15, 2005, 10:50 am ET | |
| 05/13/05 | 10th World Congress on Cancers of the Skin to Present Treatment Results from Inovio's MedPulser Electrochemical Tumor Ablation System | |
| 05/12/05 | Merck Exercises Option for Additional Antigen for Use with Inovio Biomedical's MedPulser DNA Delivery System | |
| 05/10/05 | Inovio Reports First Quarter 2005 Financial Results | |
| 04/27/05 | Inovio's President and CEO to Present at Rodman & Renshaw Techvest 2nd Global Healthcare Conference | |
| 04/04/05 | Genetronics Announces Name Change to Inovio Biomedical Corporation | |
| 04/04/05 | Inovio Biomedical and University of Southampton Collaboration: Initiation of Phase I/II Clinical Trial in Patients with Recurrent Prostate Cancer | |
| 03/23/05 | Genetronics Awarded Patent for Vascular Therapy | |
| 03/16/05 | Genetronics Biomedical Presenting at DNA Vaccines Forum | |
| 03/15/05 | Genetronics Reports 2004 Financial Results | |
| 03/01/05 | Genetronics Initiates Pancreatic Cancer Clinical Trial Using its MedPulser® Tumor Ablation System | |
| 01/26/05 | Genetronics Acquires Inovio AS | |
| 01/13/05 | H. Lee Moffitt Cancer Center and Genetronics Initiate Phase I Clinical Trial in Patients with Malignant Melanoma | |
| 01/13/05 | Genetronics Announces Equity Financing | |
| 12/15/04 | VGX Pharmaceuticals Initiates Phase I/II Clinical Trials of PICTOVIR™ for the Treatment of HIV Infection | |
| 12/01/04 | VGX Pharmaceuticals Announces FDA Acceptance of IND Application for PICTOVIR™ (formally known as VGX-410) | |
| 11/15/04 | Genetronics Reports Third Quarter 2004 Financial Results | |
| 11/09/04 | Genetronics Commences European Pre-Sale Skin Cancer Study Using its MedPulser® Electroporation Therapy System | |
| 11/01/04 | VGX Pharmaceuticals Announces IND Submission for PICTOVIR™ | |
| 10/20/04 | Genetronics and Vical Establish Worldwide License for MedPulser DNA Delivery System in Two Applications | |
| 10/20/04 | Genetronics' President and CEO to Present at Rodman & Renshaw Techvest 6th Annual Global Healthcare Conference | |
| 09/15/04 | Studies Suggest Alternatives to Surgery are Needed in Treatment of Head and Neck Cancer | |
| 09/13/04 | Genetronics Announces Reverse Stock Split | |
| 08/31/04 | Genetronics Awarded Grant by National Institutes of Health to Conduct Research for Vascular Gene Delivery | |
| 08/13/04 | Genetronics Reports Second Quarter 2004 Financial Results | |
| 08/11/04 | Genetronics Appoints Riaz Bandali to its Board of Directors | |
| 08/02/04 | Genetronics Presents Positive Results from Study of Clinical Utility of Electroporation-Mediated DNA Delivery Without Anesthesia | |
| 07/30/04 | Genetronics Biomedical Files Application to Delist from Berlin-Bremen Stock Exchange | |
| 07/28/04 | Genetronics Biomedical to Present Study Results at Gordon Research Conference on Bioelectrochemistry on July 29th | |
| 07/21/04 | Genetronics Biomedical Continues Building U.S. Patent Portfolio for Electroporation-Assisted Therapies | |
| 06/27/04 | Genetronics Awarded Two U.S. Patents for Trans-Surface and Ex Vivo Applications of Electroporation Therapy | |
| 06/07/04 | Genetronics Granted FDA Fast Track Designation for its MedPulser® Electroporation Therapy System for Head and Neck Cancer | |
| 06/03/04 | Genetronics and Chiron Present Results on Electroporation-Enhanced DNA Vaccine Delivery at American Society of Gene Therapy Annual Meeting | |
| 06/01/04 | Genetronics Biomedical Engages Dr. Michael Fons as Executive Director, Corporate Development | |
| 05/24/04 | Gentronics and Merck Sign Licensing Agreement for MedPulser® DNA Delivery System to Support DNA Vaccine Delivery | |
| 05/21/04 | Genetronics Closes $10.9 Million Preferred Stock Financing | |
| 05/18/04 | Genetronics Agrees to $10.9 Million Preferred Stock Financing | |
| 05/10/04 | Genetronics' President and CEO to Present at Rodman & Renshaw | |
| 04/13/04 | Genetronics Appoints Medical Device Manufacturing Veteran George McHugh III As VP Operations | |
| 03/09/04 | Genetronics Engages Quintiles as its Contract Research Organization (CRO) for U.S. and European Clinical Trials | |
| 03/01/04 | Genetronics Starts European Clinical Study for Primary & Recurrent Head & Neck Cancer to Advance Commercialization of the MedPulser(R) | |
| 02/23/04 | Genetronics Completes FDA Special Protocol Assessment (SPA) Process, Begins Patient Enrollment in Phase III Recurrent Head and Neck Cancer Studies | |
| 02/14/04 | Genetronics Announces Strategic Alliance | |
| 01/20/04 | Genetronics Announces Two New U.S. Patents in Electroporation Therapy and Gives an Update on its 2003 IP Development | |
| 12/18/03 | Genetronics Announces the Appointment of a New Member to its Board of Directors | |
| 12/11/03 | THE WORLD ECONOMIC FORUM DESIGNATES TECHNOLOGY PIONEERS FOR 2004: VGX PHARMACEUTICALS SELECTED | |
| 12/03/03 | Genetronics And Chiron Extend Collaborative Agreement To Explore Delivery Of HIV Vaccine | |
| 12/02/03 | Genetronics And Chiron Extend Collaborative Agreement On Technology For HIV Vaccine Delivery | |
| 11/10/03 | Genetronics Announces the Appointment of a New Member to its Board of Directors | |
| 11/03/03 | Genetronics to Present at The Wall Street Analyst Forum Conference | |
| 10/22/03 | Genetronics Meets Clinical and Regulatory Milestones and Receives Final Tranche from $15.67 Million Financing | |
| 10/21/03 | Genetronics to Present at Rodman & Renshaw Healthcare Conference | |
| 10/20/03 | Genetronics Announces Option for a License Agreement With Vical | |
| 08/27/03 | VGX Pharmaceuticals Receives A Second NIH Phase I SBIR Grant | |
| 07/16/03 | Genetronics Closes $15.67 Million Preferred Stock Financing | |
| 06/12/03 | Genetronics Announces Issuance of Two New Patents for Electroporation Therapy | |
| 06/10/03 | Genetronics Announces Collaborative Agreements With The United States Navy to Evaluate EP-enhanced Delivery Of DNA For Wound Healing | |
| 06/04/03 | Genetronics to Present Abstracts for EP-Enhanced DNA Delivery for Vaccines at the 6th American Society of Gene Therapy Annual Meeting | |
| 05/22/03 | Genetronics and Genteric Announce Agreement to Deliver DNA Into The Salivary Gland | |
| 05/15/03 | VGX Pharmaceuticals Receives NIH Grant | |
| 02/03/03 | Genetronics Provides Corporate Update | |
| 01/27/03 | Genetronics Provides Corporate Update | |
| 01/13/03 | Genetronics To Voluntarily Delist From The Toronto Stock | |
| 12/26/02 | Genetronics To Sell Its BTX(R)Division To Harvard Bioscience | |
| 12/15/02 | VGX Pharmaceuticals Receives NIH Phase I SBIR Grant | |
| 12/11/02 | Genetronics Announces New Products For High Throughput Applications | |
| 09/24/02 | Dr. Burian Presents Data From 12 Primary Head And Neck Cancer Patients Treated With Genetronics' Electroporation Therapy | |
| 09/10/02 | VGX Pharmaceuticals Receives Key Patent For Cellular Receptor For HIV-1 Vpr Essential For G2/M Phase. | |
| 08/16/02 | Genetronics Announces ICN Pharmaceuticals Will Not Complete Acquisition of BTX® Division | |
| 07/16/02 | Genetronics Appoints Peter Kies Chief Financial Officer | |
| 07/10/02 | Boehringer Ingelheim and Genetronics Sign Gene Therapy Research and Option Agreement | |
| 06/26/02 | Genetronics Provides Corporate Update | |
| 06/19/02 | Genetronics Announces The Sale Of Its BTX(R) Division To ICN Pharmaceuticals For $5 Million | |
| 06/10/02 | Genetronics Announces Advances In Electroporation-Enhanced In Vivo Gene Delivery | |
| 06/07/02 | Genetronics Announces $4.3 Million Private Placement | |
| 05/29/02 | Genetronics Names Wells Fargo As Corporate Financial Advisor | |
| 05/23/02 | Genetronics Arranges Private Placement Of Us$3,300,000 | |
| 05/23/02 | Genetronics Arranges Additional Us$900,000 In Private Placement Announced Earlier Today | |
| 05/20/02 | Genetronics' Electroporation Therapy (EPT) + Bleomycin May Increase Survival For Subjects With Recurrent Head And Neck Cancer, In Addition To Managing Loco-Regional Disease | |
| 05/08/02 | Genetronics Launches Phase III Clinical Trial Of Electroporation Therapy For Treatment Of Head And Neck Cancer | |
| 04/22/02 | Genetronics Announces Formation Of Scientific Advisory Board | |
| 03/27/02 | Genetronics Announces Efficacy Shown In Electroporation Therapy Trials At Acclaimed European Cancer Centers | |
| 03/07/02 | Genetronics To Announce Clinical Study Results At Major Cancer Conference | |
| 03/01/02 | Genetronics Provides Corporate Update | |
| 02/28/02 | Bioethics and Bioterrorism | |
| 02/11/02 | VGX's J. Joseph Kim, Chosen as One of 40 Exceptional Professionals by the | |
